Most pharmaceutical companies would be happy with 50% of the market
Ultimately if the benefits outweigh the risk people will take medication
AD is such a devastating disease as the Today tonight report showed and PBT2 allowed for a significant improvement in the life of both the patient and partner as well as potentially saving the govt more money
While the science is important the therapeutic benefit is more important we may never fully understand the MOA we still don't for Zyprexa and its just come of patent so its been used for a long time
We are on a winner
Bring it on (preferably ASAP)
GLTA
Most pharmaceutical companies would be happy with 50% of the...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $7.5K | 1.5M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 63055651 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 38008482 | 21 |
View Market Depth
| Last trade - 10.00am 12/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |